Answers are grounded in this paper and cite their sources.
This study aimed to develop a silibinin (SIL)-loaded self-micellizing solid dispersion (SMSD) with improved oral absorbability and hepatoprotective properties. A suitable polymeric carrier for the development of the SMSD system was selected based on the apparent solubility of SIL in aqueous solutions of various polymers. SIL-based SMSD (SMSD/SIL) formulations with various SIL ratios (2.5%-50% w/w) employing poloxamer 407, an amphiphilic block copolymer, were prepared via lyophilization to determine a suitable SIL-to-polymer ratio in SMSD systems. Among the tested formulations, SMSD/SIL, with a drug loading of 5%, significantly improved the dissolution behavior of SIL as evidenced by 30-fold higher dissolution than crystalline SIL. The formation of uniform fine micelles, with an average diameter of 45.8 nm after dispersion in water, could improve the dissolution properties of SMSD/SIL. Rats orally administered SMSD/SIL (50 mg-SIL/kg) exhibited enhanced oral absorption of SIL by 5.2-fold compared with crystalline SIL. In a rat model of acute hepatic injury, repeated treatment with SMSD/SIL (50 mg-SIL/kg/day for 2 days) attenuated hepatic damage as evidenced by histological observations and decreased hepatic biomarker levels. Based on these findings, the SMSD approach may be an effective strategy for enhancing the nutraceutical properties of SIL.
No takes yet. Share an insight, caveat, or question.
Banik et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: